SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-088619
Filing Date
2023-08-08
Accepted
2023-08-08 07:56:43
Documents
15
Period of Report
2023-08-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323012d3_8k.htm   iXBRL 8-K 28336
2 EXHIBIT 1.1 tm2323012d3_ex1-1.htm EX-1.1 222928
3 EXHIBIT 5.1 tm2323012d3_ex5-1.htm EX-5.1 6886
7 GRAPHIC image_001.jpg GRAPHIC 3280
  Complete submission text file 0001104659-23-088619.txt   489993

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nvax-20230808.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20230808_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20230808_pre.xml EX-101.PRE 22357
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2323012d3_8k_htm.xml XML 3206
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 231149392
SIC: 2836 Biological Products, (No Diagnostic Substances)